一、事件概述
近期,印度药品局(DepartmentofPharmaceuticals)发布国产关键原料药/中间体生产关联激励计划(ProductionLinkedIncentiveScheme)。在该激励计划中,划分了53种临床必需、存在技术含量、易于国产的原料药及中间体,并将其划分...
Copyright © 2014-2021 侠盾智库&侠盾研报网. All Rights Reserved. Power by Www.xiadun.Net 客服邮箱:yanbao_service@163.com